Related Experiment Video

Updated: May 20, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Dried blood spots and sparse sampling: a practical approach to estimating pharmacokinetic parameters of caffeine in

Parul Patel1, Hussain Mulla, Venkatesh Kairamkonda

  • 1School of Pharmacy, De Montfort University, Leicester, UK.

British Journal of Clinical Pharmacology
|July 25, 2012
PubMed

Insights

Dried blood spot (DBS) sampling is a practical method for pharmacokinetic studies in preterm infants, offering a viable alternative to traditional blood draws. This approach provides reliable caffeine pharmacokinetic modeling in this vulnerable population.

Area of Science:

  • Neonatal pharmacology
  • Analytical chemistry
  • Pediatric pharmacokinetics

Background:

  • Pharmacokinetic (PK) studies in children face challenges with traditional blood sampling.
  • Dried blood spots (DBS) offer a minimally invasive alternative for drug analysis.
  • Formal evaluation of DBS in pediatric clinical settings is limited.

Purpose of the Study:

  • To establish a pharmacokinetic (PK) model for caffeine in preterm infants using a DBS microvolume platform.
  • To assess the feasibility and reliability of DBS sampling for PK studies in neonates.
  • To compare PK parameters derived from DBS with those from plasma samples.

Main Methods:

  • Prospective collection of DBS samples from preterm infants receiving caffeine for apnoea of prematurity.
  • Development of a population PK model using non-linear mixed effects analysis on DBS caffeine concentrations.
  • Comparison of PK parameter estimates from DBS data against historical plasma data.

Main Results:

  • 338 DBS cards were collected from 67 preterm infants; 88% were of acceptable quality.
  • Minimal blood volume (≤0.5 mL) was required per child.
  • PK parameters (CL, V, t½) estimated from DBS showed good agreement with historical plasma estimates.
  • Hematocrit variations can significantly impact DBS-based PK parameter estimations.

Conclusions:

  • DBS sampling is a practical and effective method for PK studies in vulnerable preterm infants.
  • DBS provides a reliable alternative to invasive wet matrix sampling techniques in neonates.
  • Further research should consider factors like hematocrit variability in DBS analysis.
Abstract

More Related Videos

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites13:35

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

Published on: March 1, 2018

Dried Blood and Serum Spots As A Useful Tool for Sample Storage to Evaluate Cancer Biomarkers08:44

Dried Blood and Serum Spots As A Useful Tool for Sample Storage to Evaluate Cancer Biomarkers

Published on: June 11, 2018

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...